pamidronate has been researched along with Lymphoma, B-Cell in 2 studies
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To evaluate the antitumor activity of gammadelta T cells in vivo, we initiated a pilot study of low-dose interleukin 2 (IL-2) in combination with pamidronate in 19 patients with relapsed/refractory low-grade non-Hodgkin lymphoma (NHL) or multiple myeloma (MM)." | 5.10 | Gammadelta T cells for immune therapy of patients with lymphoid malignancies. ( Eckstein, S; Kunzmann, V; Reimer, P; Ruediger, T; Tony, HP; Weissinger, F; Wilhelm, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dharnidharka, VR | 1 |
| Mohanakumar, T | 1 |
| Wilhelm, M | 1 |
| Kunzmann, V | 1 |
| Eckstein, S | 1 |
| Reimer, P | 1 |
| Weissinger, F | 1 |
| Ruediger, T | 1 |
| Tony, HP | 1 |
1 trial available for pamidronate and Lymphoma, B-Cell
| Article | Year |
|---|---|
Gammadelta T cells for immune therapy of patients with lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Dose | 2003 |
1 other study available for pamidronate and Lymphoma, B-Cell
| Article | Year |
|---|---|
New approaches to treating B-cell cancers induced by Epstein-Barr virus.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Diphosphonates; Disease Models, Animal; Epstein-Barr | 2015 |